Matthias F. Kramer

Erlangen, BY 91054, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications

Microcrystalline tyrosine as a novel depot-forming agent in venom immunotherapy: a pre-clinical evaluation in bee-venom allergic mice.

Microcrystalline tyrosine as a novel depot-forming agent in venom immunotherapy: a pre-clinical evaluation in bee-venom allergic mice.

Journal: Frontiers in allergy
Published: March 27, 2026

Migraine is Related to Multiple Sclerosis Brain Lesions in the Central Pain Network with Several Migraine Phenotypes Exhibiting Different Lesion Patterns.

Migraine is Related to Multiple Sclerosis Brain Lesions in the Central Pain Network with Several Migraine Phenotypes Exhibiting Different Lesion Patterns.

Journal: Brain topography
Published: December 03, 2025

Assessing the Allergenic Relevance of Vespula alascensis Venom: Implications for Venom Immunotherapy.

Assessing the Allergenic Relevance of Vespula alascensis Venom: Implications for Venom Immunotherapy.

Journal: Journal of investigational allergology & clinical immunology
Published: November 24, 2025

Correction: Gerstlauer et al. TAPAS-A Prospective, Multicentre, Long-Term Cohort Study in Children, Adolescents and Adults with Seasonal Allergic Rhinitis-Design and Early Results. J. Clin. Med. 2025, 14, 2609.

Correction: Gerstlauer et al. TAPAS-A Prospective, Multicentre, Long-Term Cohort Study in Children, Adolescents and Adults with Seasonal Allergic Rhinitis-Design and Early Results. J. Clin. Med. 2025, 14, 2609.

Journal: Journal of clinical medicine
Published: October 09, 2025

Patient preference in allergen immunotherapy - Understanding the patient's view.

Patient preference in allergen immunotherapy - Understanding the patient's view.

Journal: The World Allergy Organization journal
Published: August 19, 2025

The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence-Based Approach.

The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence-Based Approach.

Journal: Allergy
Published: April 16, 2025

TAPAS-A Prospective, Multicentre, Long-Term Cohort Study in Children, Adolescents and Adults with Seasonal Allergic Rhinitis-Design and Early Results.

TAPAS-A Prospective, Multicentre, Long-Term Cohort Study in Children, Adolescents and Adults with Seasonal Allergic Rhinitis-Design and Early Results.

Journal: Journal of clinical medicine
Published: March 18, 2025

Meta-Analysis of PQ Grass 27600 SU Efficacy and Quality of Life From Phase III Trials.

Meta-Analysis of PQ Grass 27600 SU Efficacy and Quality of Life From Phase III Trials.

Journal: Allergy
Published: December 24, 2024

Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well-Tolerated in a Pivotal Phase III Trial.

Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well-Tolerated in a Pivotal Phase III Trial.

Journal: Allergy
Published: September 16, 2024

Modulation of Cellular, Molecular, and Humoral Responses by PQ Grass 27,600 SU for the Treatment of Seasonal Allergic Rhinitis: A Randomised Double Blind Placebo Control Exploratory Field Study.

Modulation of Cellular, Molecular, and Humoral Responses by PQ Grass 27,600 SU for the Treatment of Seasonal Allergic Rhinitis: A Randomised Double Blind Placebo Control Exploratory Field Study.

Journal: Allergy
Published: August 23, 2024

Ara h 2-expressing cucumber mosaic virus-like particle (VLP Peanut) induces in vitro tolerogenic cellular responses in peanut-allergic individuals.

Ara h 2-expressing cucumber mosaic virus-like particle (VLP Peanut) induces in vitro tolerogenic cellular responses in peanut-allergic individuals.

Journal: The Journal of allergy and clinical immunology
Published: March 01, 2024

On the role of antibody affinity and avidity in the IgE-mediated allergic response.

On the role of antibody affinity and avidity in the IgE-mediated allergic response.

Journal: Allergy
Published: February 26, 2024
Showing 1-12 of 76

Last Updated: 09/26/2026